Dear Colleagues,
It is both an honor and a pleasure for us to extend a warm welcome to the "I International Symposium on Rare Liver Diseases". This event, scheduled to be held in the city of Santander on the 11th and 12th of April, represents a unique opportunity to bring together the scientific and medical community around a common challenge: to advance our understanding and treatment of rare liver diseases.
We anticipate that this symposium will mark a significant milestone in the enhancement of knowledge and treatment of rare liver diseases, as it convenes leading experts in the field of orphan liver diseases from across the globe. Our aim is to share the latest advancements, experiences, and challenges in the diagnosis, treatment, and management of these complex conditions.
Over the course of these two days, you will have the opportunity to engage in a diverse array of sessions that include keynote lectures and highly interactive panel discussions. We trust that the scientific program will be of interest to you and will enrich your professional and academic practice.
In addition to the academic agenda, we hope that you will enjoy the hospitality of Santander, a city that melds natural beauty, historical richness, and a vibrant cultural life. We encourage you to explore its landscapes, gastronomy, and to engage with its people.
We wish to express our gratitude to all participants, speakers, sponsors, and organizers for their dedication and effort in making this event a success. Your commitment to advancing knowledge in the field of rare liver diseases is vital for the improvement of patient quality of life worldwide.
We hope that this symposium will serve not only as a platform for the dissemination of scientific knowledge but also as a venue for fostering collaboration and networking among professionals dedicated to this important cause.
Welcome to Santander and to the "I International Symposium on Rare Liver Diseases". Together, let us progress towards a future where rare liver diseases can be understood, treated, and, hopefully, cured.
Sincerely,
Javier Crespo & José Luis Calleja
👨⚕ Ángel Carracedo (Santiago de Compostela, Spain)
Chairpersons:
👨⚕ Rafael Bañares (Madrid, Spain)
👨⚕Francisco Jorquera (León, Spain)
Is there a need for specialized units?
👨⚕ Manuel Romero (Sevilla, Spain)
The role of the geneticist
👩⚕️ Nerea Paz (Santander, Spain)
Chairpersons:
👨⚕ Conrado Fernández (Madrid, Spain)
👨⚕ José Presa (Vila Real, Portugal)
Natural history in PBC
👨⚕ Christophe Corpechot (Paris, France)
Personalized treatment in PBC
👨⚕ Gideon M. Hirschfield (Toronto, Canada)
Chairpersons:
👩⚕ María Buti (Barcelona, Spain)
👨⚕ Rafael Esteban (Barcelona, Spain)
Do we know the natural history of delta hepatitis?
👨⚕ José Luis Calleja (Madrid, Spain)
Therapeutic options in hepatitis delta
👨⚕ Marc Bourlière (Marseille, France)
Real Life experience in Hepatitis delta treatment
👨⚕ Pietro Lampertico (Milan, Italy)
Porto-sinusoidal vascular disease (PSVD)
👩⚕ Virginia Hernández-Gea (Barcelona, Spain)
Fontan associated liver disease
👨⚕ Luis Téllez (Madrid, Spain)
Coffee Break & Visit Art Exhibition
Chairpersons:
👩⚕ Marina Berenguer (Valencia, Spain)
👩⚕ Elba Llop (Madrid, Spain)
What is the best treatment for Wilson’s disease today?
👨⚕ Michael L. Schilsky (New Haven, United States)
Do real-life registries improve care?
👩⚕ Zoe Mariño (Barcelona, Spain)
Chairpersons:
👨⚕ Jose Luis Calleja (Madrid, Spain)
👨⚕ JavierCrespo (Santander,Spain)
👨⚕ Julio Mayol (Madrid, Spain) v.s Clinical experts and audience
Chairpersons:
👨⚕ Jesús Bañales (San Sebastián, Spain)
👨⚕Raúl Andrade (Málaga, Spain)
Genetics of alpha 1 AT deficiency
👨⚕ Pavel Strnad (Aachen, Germany)
Progressive familial intrahepadc cholestasis
👨⚕ Richard J. Thompson (London, England)
New therapeutic options in Polycistic Liver disease
👨⚕ Joost Drenth (Nijmegen, Netherlands)
Hereditary hemochromatosis pathogenesis
👩⚕ Elena Corradini (Modena, Italy)
Chairpersons:
👩⚕ Ángela Puente (Santander, Spain)
👨⚕ Agustín Albillos (Madrid, Spain)
Integrate genomic data into clinical practice
👨⚕ Luca Valenti (Milan, Italy)
How to discover a disease: From the patient’s bedside to the laboratory
The clinician’s question
👨⚕ Álvaro Díaz (Santander, Spain)
The basic’s answer
👨⚕ José Juan García Marín (Salamanca, Spain)
MASLD genetic risk variants and personalized treatment
👨⚕ Stefano Romeo (Catanzaro, Italy)
New approaches for the treatment of liver diseases
👩⚕ Mariluz Martínez-Chantar (Derio, Spain)
Chairpersons:
👩⚕ María Teresa Arias Loste (Santander, Spain)
👨⚕ Marcos López Hoyos (Santander, Spain)
One million genomes project
👨⚕ André G. Uitterlinden (Rotterdam, Netherlands)
Cohorte Cantabria
👨⚕ Marcos López Hoyos (Santander, Spain)
👨⚕ José Luis Calleja (Madrid, Spain)
👨⚕ Javier Crespo (Santander, Spain)
🌍 Venue Information
Centro Botín
Muelle de Albareda s/n
Jardines de Pereda
Santander (Spain)
📌 SYMPOSIUM SECRETARIAT
c/Sor Ángela de la Cruz 8-28020 Madrid (Spain)
📞 +34 915551119
✉ congresos@viajesoasis.com 🌐https://viajesoasis.com/
